Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1784444

O=C(O)C(F)(F)F.O=C(O)N1CCCCC1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
MLYCD O95822 2/20 0.41
HPGD P15428 5/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TSHR P16473 1/20 0.40
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38
MMP9 P14780 1/20 0.38
CA2 P00918 1/20 0.37
CHKA P35790 1/20 0.37
DPP4 P27487 2/20 0.36
DPP8 Q6V1X1 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.35
DPP7 Q9UHL4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL14157311 0.98 MLYCD (0.42) ALDH1A1MLYCDHPGDMEN1KMT2A
Trifluoroacetic Acid SCHEMBL28214831 0.93 ALDH1A1 (0.39) ALDH1A1MLYCDHPGDMEN1KMT2A
SCHEMBL64790 0.84
SCHEMBL21291787 0.84 ALDH1A1 (0.58) ALDH1A1HPGDMEN1KMT2AMMP1
SCHEMBL6704420 0.84 ALDH1A1 (0.58) ALDH1A1HPGDMEN1KMT2AMMP1
SCHEMBL9537676 0.84 ALDH1A1 (0.58) ALDH1A1HPGDMEN1KMT2AMMP1
SCHEMBL1151783 0.84 ALDH1A1 (0.58) ALDH1A1HPGDMEN1KMT2AMMP1
Trifluoroacetic Acid SCHEMBL4524939 0.82 ALDH1A1 (0.41) ALDH1A1MLYCDHPGDMEN1KMT2A
Water SCHEMBL9407657 0.82 ALDH1A1 (0.55) ALDH1A1HPGDMEN1KMT2AMMP1
Hydrochloric Acid SCHEMBL1477069 0.82 ALDH1A1 (0.55) ALDH1A1HPGDMEN1KMT2AMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8633175-B2 Compounds as antagonists or inverse agonists at opioid receptors GLAXOSMITHKLINE LLC (US) 2014-01-21 US disclosed
US-20110124559-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2011-05-26 US disclosed
WO-2005007083-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2005-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124559-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS OPRL1, OPRM1, OPRK1 ALDH1A1 3500/4885MLYCD 4482/4885HPGD 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.